BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16556300)

  • 1. Substance abuse in first-episode schizophrenic patients: a retrospective study.
    Mauri MC; Volonteri LS; De Gaspari IF; Colasanti A; Brambilla MA; Cerruti L
    Clin Pract Epidemiol Ment Health; 2006 Mar; 2():4. PubMed ID: 16556300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes.
    Bühler B; Hambrecht M; Löffler W; an der Heiden W; Häfner H
    Schizophr Res; 2002 Apr; 54(3):243-51. PubMed ID: 11950549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.
    Wobrock T; Sittinger H; Behrendt B; D'Amelio R; Falkai P; Caspari D
    Eur Arch Psychiatry Clin Neurosci; 2007 Jun; 257(4):203-10. PubMed ID: 17131214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Do alcohol or drug abuse induce schizophrenia?].
    Hambrecht M; Häfner H
    Nervenarzt; 1996 Jan; 67(1):36-45. PubMed ID: 8676987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.
    Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
    Compr Psychiatry; 2010; 51(1):37-41. PubMed ID: 19932824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhalant abusers and psychiatric symptoms].
    Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
    Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trihexyphenidyl (Artane) abuse in schizophrenic patients.
    Zemishlany Z; Aizenberg D; Weiner Z; Weizman A
    Int Clin Psychopharmacol; 1996 Sep; 11(3):199-202. PubMed ID: 8923099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.
    Rabinowitz J; Bromet EJ; Lavelle J; Carlson G; Kovasznay B; Schwartz JE
    Psychol Med; 1998 Nov; 28(6):1411-9. PubMed ID: 9854282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and schizophrenia: results of a follow-up study.
    Caspari D
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(1):45-9. PubMed ID: 10195343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up.
    Opsal A; Clausen T; Kristensen O; Elvik I; Joa I; Larsen TK
    Acta Psychiatr Scand; 2011 Sep; 124(3):198-204. PubMed ID: 21418161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Motivational interviewing for cannabis users with psychotic disorders].
    Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
    Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of substance abuse in schizophrenia: nature and significance.
    DeQuardo JR; Carpenter CF; Tandon R
    J Psychiatr Res; 1994; 28(3):267-75. PubMed ID: 7932286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance abuse in first-episode non-affective psychosis.
    Larsen TK; Melle I; Auestad B; Friis S; Haahr U; Johannessen JO; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan TH
    Schizophr Res; 2006 Dec; 88(1-3):55-62. PubMed ID: 16971092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity.
    Gut-Fayand A; Dervaux A; Olié JP; Lôo H; Poirier MF; Krebs MO
    Psychiatry Res; 2001 May; 102(1):65-72. PubMed ID: 11368841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of cough mixture abusers referred to three substance abuse clinics in Hong Kong: a retrospective study.
    Tang AK; Tang WK; Liang HJ; Chan F; Mak SC; Ungvari GS
    East Asian Arch Psychiatry; 2012 Dec; 22(4):154-9. PubMed ID: 23271584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.